Coliseum Capital Management, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Coliseum Capital Management, LLC reported 11 stock positions worth $1.1 billion. Its top holding was Gildan Activewear (GIL) at 33.8% of the portfolio, followed by Universal Technical Institut (UTI, 13.7%) and R1 RCM (RCM, 12.2%). Compared with Q4 2023, it added to 3 and reduced 3. The biggest buy was R1 RCM (RCM, shares +94%) and the biggest sale GMS (GMS, shares −81%).
- Most Recent 13F
- Q2 2026
- Location
- Rowayton, CT
- CIK
- 0001409751
- Portfolio Value
- $1.1B (Q1 2024)
- SEC Filing
- 0000950123-24-005628 ↗ filed May 15, 2024
Holdings Value
Holdings 11 stocks · $1.1B
| GIL Gildan Activewear Inc. | 33.82% | 9,881,461 | $366.9M | No change |
| UTI Universal Technical Institut | 13.71% | 9,334,215 | $148.8M | Reduce -29.8% |
| RCM R1 RCM Inc. | 12.20% | 10,273,998 | $132.3M | Add +94.1% |
| PRPL Purple Innovation Inc. | 7.51% | 46,855,291 | $81.5M | No change |
| SONO Sonos Inc. | 6.51% | 3,703,049 | $70.6M | Reduce -37.4% |
| MODVQ Modivcare Inc. | 6.45% | 2,982,751 | $69.9M | No change |
| FTRE Fortrea Holdings Inc. | 5.71% | 1,543,652 | $62.0M | Add +4.2% |
| GMS GMS Inc. | 5.13% | 571,743 | $55.7M | Reduce -80.9% |
| MCFT Mastercraft Boat Holdings Inc. | 4.70% | 2,151,676 | $51.0M | Add +7.5% |
| LAZYDAYS HLDGS INC | 2.42% | 6,522,423 | $26.3M | No change |
| INNV Innovage Holding Corp. | 1.83% | 4,475,143 | $19.9M | No change |
Portfolio Sells Q4 2023 → Q1 2024
Portfolio Buys Q4 2023 → Q1 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 11 | $1.2B | SONO, BLDR, HRI, MBC, WSC |
| Q1 2026 | 13 | $1.2B | SONO, BLDR, HRI, UTI, WSC |
| Q4 2025 | 13 | $1.2B | SONO, HRI, MBC, UTI, NATL |
| Q3 2025 | 11 | $1.0B | SONO, HRI, NATL, MBC, UTI |
| Q2 2025 | 17 | $1.4B | GMS, HRI, SONO, ACH, UTI |
| Q1 2025 | 17 | $1.2B | GMS, HRI, UTI, SONO, ACH |
| Q4 2024 | 14 | $1.2B | GIL, UTI, SONO, GMS, HRI |
| Q3 2024 | 14 | $1.0B | GIL, UTI, SONO, GMS, HRI |
| Q2 2024 | 14 | $1.1B | GIL, UTI, RCM, MODVQ, GMS |
| Q1 2024 | 11 | $1.1B | GIL, UTI, RCM, PRPL, SONO |